Cargando…
Metformin: A Candidate Drug for Renal Diseases
Over the past decades metformin has been the optimal first-line treatment for type 2 diabetes mellitus (T2DM). Only in the last few years, it has become increasingly clear that metformin exerts benign pleiotropic actions beyond its prescribed use and ongoing investigations focus on a putative benefi...
Autores principales: | Corremans, Raphaëlle, Vervaet, Benjamin A., D’Haese, Patrick C., Neven, Ellen, Verhulst, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337137/ https://www.ncbi.nlm.nih.gov/pubmed/30583483 http://dx.doi.org/10.3390/ijms20010042 |
Ejemplares similares
-
Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect
por: Corremans, Raphaëlle, et al.
Publicado: (2023) -
L-NAME Administration Enhances Diabetic Kidney Disease Development in an STZ/NAD Rat Model
por: Corremans, Raphaëlle, et al.
Publicado: (2021) -
Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure
por: Neven, Ellen, et al.
Publicado: (2020) -
Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice
por: Le Clef, Nathalie, et al.
Publicado: (2016) -
Environmental toxin-induced acute kidney injury
por: Vervaet, Benjamin A, et al.
Publicado: (2017)